General Information of the Compound
| Compound ID |
CP0507279
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
pyridin-3-yl N-[(4-butoxyphenyl)methyl]carbamate
Show/Hide
|
||||||||||||||||||
| Synonyms |
CHEMBL596877
Pyridin-3-yl 4-butoxybenzylcarbamate
pyridin-3-yl 4-butoxybenzylcarbamate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H20N2O3
|
||||||||||||||||||
| Molecular Weight |
300.358
|
||||||||||||||||||
| Canonical SMILES |
CCCCOc1ccc(CNC(=O)Oc2cccnc2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H20N2O3/c1-2-3-11-21-15-8-6-14(7-9-15)12-19-17(20)22-16-5-4-10-18-13-16/h4-10,13H,2-3,11-12H2,1H3,(H,19,20)
Show/Hide
|
||||||||||||||||||
| InChIKey |
CZFYUEMAFQHRFG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Pyridin-3-yl 4-butoxybenzylcarbamate )
| Drug Name | Pyridin-3-yl 4-butoxybenzylcarbamate | ||
|---|---|---|---|